Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Vanda surges as FDA approves Bysanti for bipolar disorder, schizophrenia

Vanda surges as FDA approves Bysanti for bipolar disorder, schizophrenia

Feb 21, 2026

Post navigation

Kymera Therapeutics: The More This Biotech Spends, The Higher Its Valuation Rises

Replimune: Multiple Shots On Goal But A High Risk Binary Approaches

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: